NARMADA AGROBASE LIMITED
NARMADA · General/Diversified · NSE
₹35
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for NARMADA yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
4/9
Economic Moat
None
Confidence
30%
ROE
7.3%
Debt/Equity
0.17
WACC
11.1%
Market Cap
₹132.25 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
9.6%
Return on capital employed
EV / EBITDA
29.1×
Enterprise multiple
Debt / EBITDA
2.1×
Leverage vs earnings
Interest Coverage
7.1×
EBIT covers interest
Current Ratio
6.21×
Short-term liquidity
Asset Turnover
1.18×
Revenue per ₹ of assets
Revenue CAGR (3Y)
16.2%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
Ratio Trends
NARMADA · last 4 annual periods
ROE
7.3%
ROCE
9.6%
Operating Margin
—
Debt / Equity
0.17×
PE
133.5×
EV / EBITDA
47.5×
Historical Financials
NARMADA · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹35.0 Cr | ₹50.0 Cr | ₹50.3 Cr | ₹65.7 Cr | ₹78.4 Cr | +22.4% |
| EBITDA | ₹2.0 Cr | ₹2.0 Cr | ₹2.6 Cr | ₹6.2 Cr | ₹6.2 Cr | +32.7% |
| EBIT | — | ₹1.8 Cr | ₹2.3 Cr | — | — | +7.2% |
| PAT | ₹0.6 Cr | ₹0.7 Cr | ₹1.0 Cr | ₹4.1 Cr | ₹3.9 Cr | +58.7% |
| EPS (diluted) | — | ₹0.48 | ₹0.75 | — | — | +11.8% |
| CFO | ₹-0.1 Cr | ₹0.1 Cr | ₹0.9 Cr | ₹-15.9 Cr | ₹-1.3 Cr | — |
| CapEx | ₹-0.0 Cr | — | ₹-0.0 Cr | ₹-0.1 Cr | ₹-0.1 Cr | — |
| FCF | ₹-0.1 Cr | — | ₹0.9 Cr | ₹-16.0 Cr | ₹-1.4 Cr | — |
| Total Assets | ₹26.5 Cr | ₹27.3 Cr | ₹28.0 Cr | ₹66.5 Cr | ₹72.3 Cr | +28.5% |
| Total Debt | ₹9.7 Cr | ₹10.1 Cr | ₹9.7 Cr | ₹9.5 Cr | ₹10.1 Cr | +0.9% |
| Shareholders' Equity | ₹15.2 Cr | ₹15.9 Cr | ₹16.9 Cr | ₹55.9 Cr | ₹59.3 Cr | +40.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
NARMADA vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
OSWALSEEDS OSWALSEEDS | — | — | Pending | 8.1% | — |
SIKKO SIKKO | — | — | Pending | 5.2% | — |
INDOUS INDO US BIOTECH LTD | +50.7%+102.9% upside | 40 | Data Limited | 14.2% | — |
NAGAFERT NAGAFERT | — | — | Pending | — | — |
NOVAAGRI NOVAAGRI | — | — | Pending | 12.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
1 ex-dividend event on file. Source: NSE corporate-actions feed.
Total paid (5Y)
—
Last payout
2019-09-18
₹0.04
Peak payout
₹0.04
Trailing yield
—
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of NARMADA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for NARMADA →
Compare
Head-to-head with peers
Compare NARMADA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse NARMADANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.